MXPA06000276A - Indolinona hidrazidas como inhibidores de c-met. - Google Patents
Indolinona hidrazidas como inhibidores de c-met.Info
- Publication number
- MXPA06000276A MXPA06000276A MXPA06000276A MXPA06000276A MXPA06000276A MX PA06000276 A MXPA06000276 A MX PA06000276A MX PA06000276 A MXPA06000276 A MX PA06000276A MX PA06000276 A MXPA06000276 A MX PA06000276A MX PA06000276 A MXPA06000276 A MX PA06000276A
- Authority
- MX
- Mexico
- Prior art keywords
- met inhibitors
- met
- indolinone
- hydrazides
- indolinone hydrazides
- Prior art date
Links
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 title 1
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical compound C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
La presente invencion se refiere a compuestos de las formulas (I) - (XII), en las que R1-R71, A, B, X, Y, G, L y Z se definen en el presente documento, y sus sales farmaceuticamente aceptables; estos compuestos modulan la actividad de c-Met y se espera por lo tanto que sean utiles en la prevencion y tratamiento de trastornos relacionados con c-Met tales como el cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48422303P | 2003-07-02 | 2003-07-02 | |
PCT/US2004/017423 WO2005005378A2 (en) | 2003-07-02 | 2004-06-25 | Indolinone hydrazides as c-met inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA06000276A true MXPA06000276A (es) | 2006-04-07 |
Family
ID=34062035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA06000276A MXPA06000276A (es) | 2003-07-02 | 2004-06-25 | Indolinona hidrazidas como inhibidores de c-met. |
Country Status (6)
Country | Link |
---|---|
US (1) | US20060009493A1 (es) |
EP (1) | EP1644362A2 (es) |
BR (1) | BRPI0412040A (es) |
CA (1) | CA2529622A1 (es) |
MX (1) | MXPA06000276A (es) |
WO (1) | WO2005005378A2 (es) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006101937A1 (en) * | 2005-03-18 | 2006-09-28 | Janssen Pharmaceutica N.V. | Acylhydrazones as kinase modulators |
ES2424651T3 (es) | 2005-08-24 | 2013-10-07 | Eisai R&D Management Co., Ltd. | Nuevo derivado de piridina y derivado de pirimidina (3) |
KR20080110783A (ko) | 2006-03-07 | 2008-12-19 | 어레이 바이오파마 인크. | 헤테로바이시클릭 피라졸 화합물 및 사용 방법 |
US20110053931A1 (en) * | 2006-06-08 | 2011-03-03 | John Gaudino | Quinoline compounds and methods of use |
CA2660836A1 (en) | 2006-08-07 | 2008-02-21 | Incyte Corporation | Triazolotriazines as kinase inhibitors |
WO2008023698A1 (fr) | 2006-08-23 | 2008-02-28 | Eisai R & D Management Co., Ltd. | Sel de dérivé de phénoxypyridine ou son cristal et procédé de production |
US7790885B2 (en) | 2006-08-31 | 2010-09-07 | Eisai R&D Management Co., Ltd. | Process for preparing phenoxypyridine derivatives |
WO2008051547A1 (en) | 2006-10-23 | 2008-05-02 | Cephalon, Inc. | Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors |
NO346024B1 (no) | 2006-11-22 | 2022-01-03 | Incyte Holdings Corp | Imidazotriaziner og imidazopyrimidiner som kinaseinhibitorer |
MY148851A (en) | 2006-12-14 | 2013-06-14 | Bayer Ip Gmbh | Dihydropyridine derivatives as useful as protein kinase inhibitors |
ES2686019T3 (es) | 2007-05-22 | 2018-10-16 | Wyeth Llc | Procedimientos mejorados de fabricación de hidrazidas |
JP2009132660A (ja) | 2007-11-30 | 2009-06-18 | Eisai R & D Management Co Ltd | 食道癌治療用組成物 |
US10022558B1 (en) | 2008-01-07 | 2018-07-17 | Salutaris Medical Devices, Inc. | Methods and devices for minimally-invasive delivery of radiation to the eye |
US9873001B2 (en) | 2008-01-07 | 2018-01-23 | Salutaris Medical Devices, Inc. | Methods and devices for minimally-invasive delivery of radiation to the eye |
US9056201B1 (en) | 2008-01-07 | 2015-06-16 | Salutaris Medical Devices, Inc. | Methods and devices for minimally-invasive delivery of radiation to the eye |
KR101691368B1 (ko) * | 2008-01-07 | 2016-12-30 | 살루타리스 메디컬 디바이스즈, 인코퍼레이티드 | 눈의 후부에 대한 방사선의 전달을 위한 외안의 최소한의 수술 장치 |
US8602959B1 (en) | 2010-05-21 | 2013-12-10 | Robert Park | Methods and devices for delivery of radiation to the posterior portion of the eye |
US8608632B1 (en) | 2009-07-03 | 2013-12-17 | Salutaris Medical Devices, Inc. | Methods and devices for minimally-invasive extraocular delivery of radiation and/or pharmaceutics to the posterior portion of the eye |
NZ589622A (en) | 2008-05-21 | 2012-10-26 | Incyte Corp | Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
MX2011002082A (es) * | 2008-08-29 | 2011-06-20 | Genentech Inc | Diagnostico y tratamientos para los tumores independientes del vegf. |
USD691270S1 (en) | 2009-01-07 | 2013-10-08 | Salutaris Medical Devices, Inc. | Fixed-shape cannula for posterior delivery of radiation to an eye |
USD691269S1 (en) | 2009-01-07 | 2013-10-08 | Salutaris Medical Devices, Inc. | Fixed-shape cannula for posterior delivery of radiation to an eye |
USD691267S1 (en) | 2009-01-07 | 2013-10-08 | Salutaris Medical Devices, Inc. | Fixed-shape cannula for posterior delivery of radiation to eye |
USD691268S1 (en) | 2009-01-07 | 2013-10-08 | Salutaris Medical Devices, Inc. | Fixed-shape cannula for posterior delivery of radiation to eye |
WO2011053908A1 (en) * | 2009-11-02 | 2011-05-05 | Salutaris Medical Devices, Inc. | Methods and devices for delivering appropriate minimally-invasive extraocular radiation |
JP2011152261A (ja) * | 2010-01-27 | 2011-08-11 | Nippon Koden Corp | 携帯型生体信号測定・送信システム |
JP5714030B2 (ja) | 2010-02-03 | 2015-05-07 | インサイト コーポレーションIncyte Corporation | C−Met阻害剤としてのイミダゾ[1,2−b][1,2,4]トリアジン |
AU2011237642B2 (en) * | 2010-04-06 | 2014-05-01 | Brigham Young University | Antimetastatic compounds |
US9265739B2 (en) | 2010-06-02 | 2016-02-23 | The Trustees Of The University Of Pennsylvania | Methods and use of compounds that bind to HER2/neu receptor complex |
WO2011153049A1 (en) | 2010-06-02 | 2011-12-08 | The Trustees Of The University Of Pennsylvania | Methods and use of compounds that bind to her2/neu receptor complex |
CN102532141A (zh) | 2010-12-08 | 2012-07-04 | 中国科学院上海药物研究所 | [1,2,4]三唑并[4,3-b][1,2,4]三嗪类化合物、其制备方法和用途 |
WO2013152252A1 (en) | 2012-04-06 | 2013-10-10 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
BR112016021383A2 (pt) | 2014-03-24 | 2017-10-03 | Genentech Inc | Método para identificar um paciente com câncer que é susceptível ou menos susceptível a responder ao tratamento com um antagonista de cmet, método para identificar um paciente apresentando câncer previamente tratado, método para determinar a expressão do biomarcador hgf, antagonista anti-c-met e seu uso, kit de diagnóstico e seu método de preparo |
CN105272995B (zh) * | 2015-09-24 | 2017-10-27 | 上海海聚生物科技有限公司 | 喹啉类衍生物、其药物组合物、制备方法及应用 |
CN108853108A (zh) * | 2015-12-31 | 2018-11-23 | 北京浦润奥生物科技有限责任公司 | 化合物在制备用于治疗脑胶质瘤的药物中的用途 |
USD814638S1 (en) | 2016-05-11 | 2018-04-03 | Salutaris Medical Devices, Inc. | Brachytherapy device |
USD814637S1 (en) | 2016-05-11 | 2018-04-03 | Salutaris Medical Devices, Inc. | Brachytherapy device |
USD815285S1 (en) | 2016-05-11 | 2018-04-10 | Salutaris Medical Devices, Inc. | Brachytherapy device |
USD808529S1 (en) | 2016-08-31 | 2018-01-23 | Salutaris Medical Devices, Inc. | Holder for a brachytherapy device |
USD808528S1 (en) | 2016-08-31 | 2018-01-23 | Salutaris Medical Devices, Inc. | Holder for a brachytherapy device |
CA3084092A1 (en) | 2017-12-06 | 2019-06-13 | Ontario Institute For Cancer Research (Oicr) | Acyl hydrazone linkers, methods and uses thereof |
CA3140802A1 (en) * | 2019-06-12 | 2020-12-17 | Ontario Institute For Cancer Research (Oicr) | Unsaturated heterocycloalkyl and heteroaromatic acyl hydrazone linkers, methods and uses thereof |
US11945809B2 (en) | 2020-07-19 | 2024-04-02 | King Saud University | Isatin derivatives |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60123485A (ja) * | 1983-12-08 | 1985-07-02 | Yoshitomi Pharmaceut Ind Ltd | インド−ル−3−カルボキサミド誘導体 |
US5217999A (en) * | 1987-12-24 | 1993-06-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Styryl compounds which inhibit EGF receptor protein tyrosine kinase |
US5302606A (en) * | 1990-04-16 | 1994-04-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase |
US5330992A (en) * | 1992-10-23 | 1994-07-19 | Sterling Winthrop Inc. | 1-cyclopropyl-4-pyridyl-quinolinones |
-
2004
- 2004-06-25 EP EP04754107A patent/EP1644362A2/en not_active Withdrawn
- 2004-06-25 CA CA002529622A patent/CA2529622A1/en not_active Abandoned
- 2004-06-25 MX MXPA06000276A patent/MXPA06000276A/es unknown
- 2004-06-25 US US10/875,508 patent/US20060009493A1/en not_active Abandoned
- 2004-06-25 WO PCT/US2004/017423 patent/WO2005005378A2/en not_active Application Discontinuation
- 2004-06-25 BR BRPI0412040-0A patent/BRPI0412040A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2005005378A2 (en) | 2005-01-20 |
EP1644362A2 (en) | 2006-04-12 |
BRPI0412040A (pt) | 2006-09-05 |
US20060009493A1 (en) | 2006-01-12 |
WO2005005378A3 (en) | 2005-03-03 |
CA2529622A1 (en) | 2005-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA06000276A (es) | Indolinona hidrazidas como inhibidores de c-met. | |
HK1091121A1 (en) | Substituted 2-aminotetralins for the treatment of depressions | |
WO2005004808A3 (en) | TETRACYCLIC COMPOUNDS AS c-MET INHIBITORS | |
HK1079519A1 (en) | Furyl compounds | |
HK1079522A1 (en) | Thienyl compounds | |
WO2007024717A3 (en) | Agents for preventing and treating disorders involving modulation of the ryr receptors | |
TW200407305A (en) | Novel compounds | |
TW200621715A (en) | Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors | |
MY135841A (en) | Novel benzodioxoles | |
YU21702A (sh) | Supstituisani indoli za moduliranje nfkb aktivnosti | |
MXPA06000091A (es) | Arilmetiltriazolo e imidazopirazinas como inhibidores de c-met. | |
EA200701467A1 (ru) | Пирролидиновые ингибиторы иап (ингибиторов апоптоза) | |
RS20050104A (en) | Indole or benzimidazole derivatives for modulating ikb kinase | |
TW200510301A (en) | Novel compounds | |
HK1080470A1 (en) | Heterocyclic compounds | |
TW200510303A (en) | Novel compounds | |
TW200736229A (en) | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors | |
UA84712C2 (en) | N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors | |
MXPA06009475A (es) | Derivados de quinazolina y usos terapeuticos de los mismos. | |
MX2007000224A (es) | Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos. | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
WO2006124865A3 (en) | Biaryls derivatives useful as modulators of ion channels | |
MX2009005242A (es) | Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo. | |
PL1732902T3 (pl) | Pochodne nukleozydów i ich terapeutyczne zastosowanie | |
TW200616951A (en) | Indole derivatives, their manufacture and use as pharmaceutial agents |